Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

SELL
$15.44 - $24.23 $7,766 - $12,187
-503 Closed
0 $0
Q3 2020

Nov 02, 2020

SELL
$19.43 - $35.36 $16,204 - $29,490
-834 Reduced 62.38%
503 $10,000
Q2 2020

Aug 11, 2020

BUY
$29.41 - $51.23 $39,115 - $68,135
1,330 Added 19000.0%
1,337 $49,000
Q1 2020

May 15, 2020

BUY
$19.54 - $55.47 $136 - $388
7 New
7 $0

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $27.4M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.